JP Morgan Chase’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.33M Buy
+20,000
New +$1.35M ﹤0.01% 4583
2025
Q4
– Sell
-800
Closed -$60.1K – 7545
2025
Q3
$60.1K Buy
+800
New +$59.7K ﹤0.01% 6165

Other funds holding GEHC

JP Morgan Chase's GEHC Position: Q3 2026 in Review

JP Morgan Chase reduced its GE HealthCare (GEHC) stake by 21% in Q3 2026, selling an estimated $148M and leaving 8,143,594 shares worth $541M. The position accounts for 0.03% of the portfolio, ranked #415.

JP Morgan Chase first reported a position in GEHC in Q4 2022 and has held it in 16 quarters since. The position peaked at $672M in Q2 2026. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • JP Morgan Chase held 8,143,594 shares of GE HealthCare worth $541M as of Q3 2026.
  • JP Morgan Chase sold 2,185,570 GE HealthCare shares in Q3 2026, an estimated $148M.
  • GE HealthCare made up 0.03% of JP Morgan Chase's portfolio in Q3 2026, its #415 holding.
  • JP Morgan Chase first reported a position in GE HealthCare in Q4 2022 and has held it in 16 quarters since.
  • JP Morgan Chase's GE HealthCare position peaked at $672M in Q2 2026.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.